Holding(s) in Company

RNS Number : 0200W
Dechra Pharmaceuticals PLC
11 November 2010
 



 

 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

 

Dechra Pharmaceuticals Plc

 

 

2 Reason for the notification (please tick the appropriate box or boxes):

 

An acquisition or disposal of voting rights


Yes

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


 

An event changing the breakdown of voting rights


 

Other (please specify):

 


 

3. Full name of person(s) subject to the notification obligation:

 


Legal &  General Group Plc (L&G)

4. Full name of shareholder(s) (if different from 3.):

 

Legal & General Assurance (Pensions Management) Limited (PMC)

5. Date of the transaction and date on which the threshold is crossed or reached:

 

08 November 2010

6. Date on which issuer notified:

 

10 November 2010

7. Threshold(s) that is/are crossed or reached:

 

L&G (From 4% to 5%)

 

8. Notified details:

A: Voting rights attached to shares

 

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights

 

Direct

Indirect

Direct

Indirect


GBP 0.01

3,270,269

 

(As on 22/10/2009)


 

3,471,513

3,471,513


5.24%



 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financial
instrument

Expiration
date

Exercise/
Conversion
Period

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

 

% of voting
rights






 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financial
instrument

Exercise
price

Expiration
date

Exercise/
Conversion
period

Number of voting
rights instrument
refers to

% of voting rights

 






Nominal

Delta

 



 

Total (A+B+C)

 

Number of voting rights

Percentage of voting rights


3,471,513


5.24%

 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:

 

 

Legal & General Group Plc (Direct and Indirect) (Group) (4,218,678 – 6.37% = Total Position)
 
 
Legal & General Investment Management (Holdings) Limited (LGIMH) (Direct and Indirect) 
 (4,218,678 – 6.37% = Total Position)
 
 
Legal & General Investment Management Limited (Indirect) (LGIM) (4,218,678 – 6.37% = Total Position)
 
 
Legal & General Group Plc (Direct) (L&G) ( 3,471,513 – 5.24% = LGAS, LGPL & PMC)
 
Legal & General Investment Management (Holdings) Limited (Direct) (LGIMHD) (2,097,282 – 3.17% = PMC) 
 
Legal & General Insurance Holdings Limited (Direct)
 (LGIH) (LGAS & LGPL)
 
Legal & General Assurance (Pensions Management) Limited  (PMC) (2,097,282 – 3.17% = PMC)
Legal & General Assurance Society Limited 
(LGAS & LGPL) (LGAS & LGPL)
 
 
 
Legal & General Pensions Limited (Direct)  (LGPL)

 

Proxy Voting:

 

10. Name of the proxy holder:

 

N/A

11. Number of voting rights proxy holder will cease to hold:

 

N/A

12. Date on which proxy holder will cease to hold voting rights:

 

N/A

 

13. Additional information:

 

Notification using the total voting rights figure of 66,146,877

14. Contact name:

 

Paul Toon (LGIM)

15. Contact telephone number:

 

020 3124 3854

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLMMMMMGMRGGZM
UK 100

Latest directors dealings